ÂÜÀòÂÒÂ×

JW

Jon Weston

Head of Business Development, Interim CFO at ENZYME BY DESIGN

Jon Weston has a diverse and extensive work experience in the biotechnology and pharmaceutical industry.

Jon is currently working at Enzyme by Design as the Head of Business Development and Interim CFO. In this role, they focus on engineering safer cancer therapeutics by analyzing the 3-dimensional structure of proteins and introducing minor mutations to optimize efficacy and minimize side effects.

Prior to their current role, Jon was the Managing Partner at Weston BioConsulting, where they helped companies transform benchtop discoveries into sellable bedside innovations. Jon provided market analysis, developed strategies, and implemented tactical plans to align client technologies with market needs.

Jon also served as the President and CEO of PhotonPharma, Inc, an immune oncology company. Jon led the development of Innocell, a breakthrough technology that stimulates a patient's immune system to seek out and destroy cancer cells.

Before that, Jon held the position of President and CEO at BioCare Systems, Inc, where they conducted market analysis, developed product strategies, and secured investment to launch the LumiWave product line.

Additionally, Jon has experience as the Vice President and COO at BioCare Systems, Inc, as well as the Chief Commercialization Officer at NAVIGANT BIOTECHNOLOGIES, where they contributed to strategic vision and product design.

Earlier in their career, Jon worked in marketing and business development at Gambro BCT, where they played a crucial role in capturing dominant market share in blood collections.

Jon started their career at G.D. Searle (now Pfizer) as the Director of Arthritis Products, where they led the international commercialization of Arthrotec and participated in the development and execution of clinical trials for various arthritis drugs.

Overall, Jon Weston brings a wealth of experience in business development, strategic planning, and market analysis to the biotechnology and pharmaceutical industry.

Jon Weston earned their Bachelor of Arts degree in Molecular Biology from the University of Colorado Boulder, where they attended from 1978 to 1982. Jon further pursued their education at the University of Denver, completing their Master of Business Administration degree in Marketing and Management from 1983 to 1985. Prior to their university education, there is no specified information available about their educational journey at Wheat Ridge.

Links